Loading stock data...

Shukra Pharmaceuticals Limited

BSE: SHUKRAPHAR

BSE
39.10 1.65 (4.41%)

Prev Close

37.45

Open Price

37.75

Volume

348,789

Today Low / High

37 / 39.1

52 WK Low / High

11.74 / 65.26

Range

37 - 41

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 39.1, reflecting a change of 1.65 (4.40587%). The expected target range on the BSE is 37 - 41. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

25 Feb 37.75 3.50%
24 Feb 35.82 4.55%
23 Feb 37.87 -5.15%
20 Feb 39.50 -5.22%
19 Feb 39.39 0.03%
18 Feb 40.26 -2.16%
17 Feb 42.50 -2.96%
16 Feb 39.50 6.58%
13 Feb 40.13 0.00%
12 Feb 42.24 0.00%
11 Feb 46.60 -4.59%
10 Feb 45.50 2.84%
09 Feb 44.57 0.00%
06 Feb 42.45 0.00%
05 Feb 40.43 0.00%
04 Feb 39.60 -2.75%
03 Feb 38.49 2.91%
02 Feb 39.18 -3.57%
01 Feb 38.55 3.06%
30 Jan 40.78 -0.66%
29 Jan 40.00 6.60%
28 Jan 40.62 0.00%

Shukra Pharmaceuticals Limited Graph

Shukra Pharmaceuticals Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Shukra Pharmaceuticals Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 39.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 39.10 39.49 35.54 - 43.44
39.88 31.91 - 47.86
40.27 28.19 - 52.35
Bearish Scenario 39.10 38.71 34.84 - 42.58
38.32 30.65 - 45.98
37.93 26.55 - 49.31

Overview of Shukra Pharmaceuticals Limited

ISIN

INE551C01044

Industry

Medical - Pharmaceuticals

Vol.Avg

331,460

Market Cap

17,121,086,104

Last Dividend

0.02

Official Website

Visit Website

IPO Date

1998-12-30

DCF Diff

35.51

DCF

3

Financial Ratios Every Investor Needs

Stock Dividend of SHUKRAPHAR

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-09-23 September 23, 25 0.01 0.01 2025-09-23 2025-10-30
2025-09-18 September 18, 25 0.01 0.01 2025-09-18 2025-10-30
2024-09-23 September 23, 24 0.1 1 2024-09-23 2024-10-30
2023-09-15 September 15, 23 0.125 5 2023-09-15 2023-10-22
2022-09-22 September 22, 22 0.026017 4.9994 2022-09-22 2022-10-29

Stock Rating Details for SHUKRAPHAR

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 32.59 Cr 8.11 Cr 24.48 Cr 0.7511 0.00 Cr 6.84 Cr 9.72 Cr 9.58 Cr 0.22 16.94 Cr 0.2938
2024-03-31 74.57 Cr 44.53 Cr 30.04 Cr 0.4028 0.13 Cr 0.67 Cr 17.35 Cr 18.54 Cr 4.23 22.22 Cr 0.2486
2023-03-31 58.83 Cr 45.43 Cr 13.41 Cr 0.2279 0.12 Cr 0.60 Cr 4.62 Cr 4.41 Cr 6.55 6.53 Cr 0.0749
2022-03-31 20.49 Cr 10.52 Cr 9.97 Cr 0.4866 0.09 Cr 0.43 Cr 1.24 Cr 0.75 Cr 0.25 2.96 Cr 0.0366
2021-03-31 11.20 Cr 2.77 Cr 8.43 Cr 0.7526 0.05 Cr 0.19 Cr 0.28 Cr 0.19 Cr 0.01 1.60 Cr 0.0168

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 12.12 Cr 86.77 Cr 23.93 Cr 62.8358 Cr 4.18 Cr -7.94 Cr 9.95 Cr 21.34 Cr 0.00 Cr 0.00 Cr 0.00 Cr 17.2836 Cr
2024-03-31 9.98 Cr 77.84 Cr 20.20 Cr 57.6396 Cr 3.15 Cr -6.83 Cr 2.31 Cr 21.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 14.1532 Cr
2023-03-31 3.97 Cr 74.97 Cr 49.67 Cr 25.2967 Cr 5.08 Cr 1.11 Cr 3.16 Cr 21.89 Cr 6.61 Cr 0.00 Cr 0.21 Cr 42.5062 Cr
2022-03-31 0.29 Cr 35.11 Cr 18.76 Cr 16.3500 Cr 3.38 Cr 3.09 Cr 3.95 Cr 19.24 Cr 0.00 Cr 0.00 Cr 0.20 Cr 12.3765 Cr
2021-03-31 0.50 Cr 35.61 Cr 20.01 Cr 15.5993 Cr 9.77 Cr 9.27 Cr 1.68 Cr 19.35 Cr 0.84 Cr 0.00 Cr 0.19 Cr 7.0349 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 7.9184 Cr -1.2636 Cr -4.5175 Cr 5.1754 Cr 2.1373 Cr 12.1177 Cr -2.7430 Cr 13.3366 Cr 0.4562 Cr -4.3788 Cr -7.6386 Cr
2024-03-31 -5.1967 Cr -1.2009 Cr 12.4050 Cr -6.9567 Cr 6.0075 Cr 9.9804 Cr -1.7600 Cr 18.5372 Cr -1.1117 Cr -0.0702 Cr 0.8423 Cr
2023-03-31 3.1695 Cr -4.4271 Cr 4.9411 Cr -1.3215 Cr 3.6835 Cr 3.9731 Cr -4.4910 Cr 4.4417 Cr 0.6416 Cr -0.0728 Cr 0.7973 Cr
2022-03-31 7.9885 Cr -1.5280 Cr -6.6753 Cr 6.4385 Cr -0.2148 Cr 0.2896 Cr -1.5500 Cr 1.0180 Cr -6.3940 Cr 0.0000 Cr -2.2724 Cr
2021-03-31 0.5373 Cr -1.8948 Cr 1.7355 Cr -1.2539 Cr 0.3780 Cr 0.5044 Cr -1.7912 Cr 0.0978 Cr 1.7355 Cr 0.0000 Cr -0.2949 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 39.13 Cr 10.62 Cr 28.52 Cr 0.7286 26.30 Cr 20.36 Cr 0.47 27.95 Cr 0.5204
2025-09-30 5.88 Cr 2.00 Cr 3.87 Cr 0.6589 -1.23 Cr 2.38 Cr 0.05 1.29 Cr 0.4046
2025-06-30 5.39 Cr 0.77 Cr 4.62 Cr 0.8571 0.53 Cr 1.03 Cr 0.02 2.43 Cr 0.1910
2025-03-31 13.27 Cr 1.76 Cr 11.51 Cr 0.8672 6.38 Cr 5.39 Cr 0.12 8.78 Cr 0.4059
2024-12-31 10.58 Cr 3.95 Cr 6.63 Cr 0.6264 3.24 Cr 3.16 Cr 0.72 4.94 Cr 0.2990

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.00 Cr 13.36 Cr 13.36 Cr 9.39 Cr 15.90 Cr 66.37 Cr 20.87 Cr 87.23 Cr 21.43 Cr
2025-06-30 0.00 Cr 0.00 Cr 12.12 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -62.84 Cr
2025-03-31 12.12 Cr 0.00 Cr 12.12 Cr 19.00 Cr 9.95 Cr 65.43 Cr 21.34 Cr 86.77 Cr 23.93 Cr
2024-12-31 0.00 Cr 0.00 Cr 18.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -54.29 Cr
2024-09-30 18.03 Cr 0.00 Cr 18.03 Cr 6.43 Cr 4.45 Cr 59.32 Cr 21.35 Cr 80.67 Cr 26.38 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 5.39 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 3.16 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 0.54 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.49 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2025-03-21 March 21, 25 10:1
2024-04-19 April 19, 24 4:1
2023-02-02 February 02, 23 1201:250
2015-04-06 April 06, 15 1:40
2014-03-10 March 10, 14 1:40

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹854.00 ₹102,482,887,374.00 ₹242,221.00

Key Executives

Chairman & MD
Dakshesh Rameshchandra Shah

Gender: male

Year Born: 1972

Additional Executive Director
Dhruvin Daksheshbhai Shah

Gender: male

Year Born: 1996

Additional Executive Director
Sanskruti Jayeshbhai Patel

Gender: female

Year Born: 1996

Chief Financial Officer & Whole Time Director
Anar Jayesh Patel

Gender: female

Year Born: 1970

Company Secretary & Compliance Officer
Arpita Kabra

Gender: female

Year Born: 1993

Executive Director
Payalben Sujay Mehta

Gender: female

Year Born: 1980

Whole-Time Director
Shital Shah

Gender: female

Year Born:

FAQs about Shukra Pharmaceuticals Limited

Who is the CEO of the company?

The CEO is Dakshesh Rameshchandra Shah.

What is the current market price of the stock?

The current price is ₹39.10.

What is the 52-week price range?

The range is ₹11.74-65.26.

What is the market capitalization of the company?

The market capitalization is ₹1,712.11 crores.

What is the dividend yield?

The dividend yield is 0.05%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 58.10.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Shukra Pharmaceuticals Limited (ISIN: INE551C01044) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹1,712.11 crores and an average daily volume of 331,460 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.02.